Amelioration of cisplatin-induced nephrotoxicity in mice by oral administration of diphenylmethyl selenocyanate

Free Radical Research

Volumn 45, Issue 2, 2011, Pages 177-187

  Chakraborty, Pramita ^a   Roy, Somnath Singha ^a   Sk, Ugir Hossain ^b   Bhattacharya, Sudin ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Cisplatin; Diphenylmethyl selenocyanate; Nephrotoxicity; Oxidative stress

Indexed keywords

CATALASE; CISPLATIN; CREATININE; CYCLOOXYGENASE 2; DIPHENYLMETHYL SELENOCYANATE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; ORGANOSELENIUM DERIVATIVE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

CELL DAMAGE; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG SYNTHESIS; ENZYME ACTIVITY; IN VIVO STUDY; KIDNEY TUBULE CELL; LIPID PEROXIDATION; LIVER PROTECTION; NEPHROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SWISS WEBSTER MOUSE; UREA NITROGEN BLOOD LEVEL;

ADMINISTRATION, ORAL; ANIMALS; CATALASE; CISPLATIN; CREATININE; CYCLOOXYGENASE 2; GENE EXPRESSION; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY NEOPLASMS; LIPID PEROXIDATION; MALE; MICE; NITRIC OXIDE SYNTHASE TYPE II; ORGANOSELENIUM COMPOUNDS; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

MUS;

EID: 78651269457     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2010.521155     Document Type: Review

References (54)

1. Rosenberg B. Fundamental studies with cisplatin. Cancer 1985;55:2303-23l6.
2. Coste F, Malinge JM, Serre L, Shepard W, Roth M, Leng M, Zelwer C. Crystal structure of a double-stranded DNA containing a cisplatin intrastrand cross-link at 1.63 Å resolution-hydration at the platinated site. Nucleic Acids Res 1999;27: 1837-1846.
3. Kartalou M, Essigmann JM. Recognition of cisplatin adducts by cellular proteins. Mutat Res 2001;478:1-21.
4. Safirstein RL. Renal diseases induced by anti-neoplastica-gents. In: Schrier RW, editor. Diseases of the kidney and urinary tract. Philadelphia, PA: Lippincott Williams & Wilkins; 2001. 1175-1188.
5. Masuda H, Tanaka T, Takahama UT. Cisplatin generates superoxide anion by interaction with DNA in a cell-free system. Biochem Biophys Res Commun 1994;203:1175-1180.
6. Baliga R, Zhang Z, Baliga M, Ueda N, Shah S. In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int 1998;53:394-401.
7. Matsushima H, Yonemura K, Ohishi K, Hishida A. The role of oxygen free radicals in cisplatin-induced acute renal failure in rats. J Lab Clin Med 1998;131:518-26.
8. Sadzuka Y, Shoji T, Takino Y. Effect of cisplatin on the activities of enzymes which protect against lipid peroxidation. Bio-chem Pharmacol 1992;43:1873-1875.
9. Safi rstein R, Miller P, Guttenplan JB. Uptake and metabolism of cisplatin by rat kidney. Kidney Int 1984;25:753-758.
10. Conklin KA. Dietary antioxidants during cancer chemotherapy impact on chemotherapeutic effectiveness and development on side effects. Nutr Cancer 2000;37:1-18.
11. Ozardali I, Bitiren M, Karakilçik AZ, Zerin M, Aksoy N, Musa D. Effects of selenium on histopathological and enzymatic changes in experimental liver injury of rats. Exp Toxicol Pathol 2004;56:59-64.
12. Yan L, Yee JA, Li D, McGuire M, Graef GL. Dietary supplementation of selenomethionine reduces metastasis of melanoma cells in mice. Anticancer Res 1999; 19:1337-1342.
13. Arenholt-Bendsleve D, Abdulla M, Jepsrn A, Pedeson E. Effect of organic and inorganic selenium on human keratino-cytes. Trace Elem Med 1988;5:29-34.
14. Khalil AM. Genotoxicity of two pharmacologically important selenium compounds (selenocystine and selenopuridine) in cultured human blood lymphocytes. Toxicol Environ Chem 1994;41:147-154.
15. Nogueira CW, Zeni G, Rocha JB. Organoselenium and orga-notellurium compounds: toxicology and pharmacology. Chem Rev 2004;104:6255-6285.
16. Meotti FC, Stangherlin EC, Zeni G, Nogueira CW, Rocha JB. Protective role of aryl and alkyl diselenides on lipid per-oxidation. Environ Res 2004;94:276-282.
17. Das RK, Das S, Bhattacharya S. Protective effect of diphe-nylmethyl selenocyanate against carbon tetrachloride induced hepatotoxicity in vivo . J Environ Path Toxicol Oncol 2004;23: 287-296.
18. Ghosh S, Das RK, Sengupta A, Bhattacharya S. Induction of apoptosis and inhibition of cell proliferation by diphenylme-thyl selenocyanate during azoxymethane induced rat colon carcinogenesis. Int J Cancer Prev 2005;2:63-70.
19. Chakraborty P, Sk HU, Murmu N, Das JK, Pal S, Bhattach-arya S. Modulation of cyclophosphamide-induced cellular toxicity by diphenylmethyl selenocyanate in vivo, an enzymatic study. J Cancer Molecules 2009;4:183-189.
20. Chakraborty P, Sk HU, Bhattacharya S. Chemoprotection and enhancement of cancer chemotherapeutic effi cacy of cyclophosphamide in mice bearing Ehrlich ascites carcinoma by diphenylmethyl selenocyanate. Cancer Chemother Pharmacol 2009;64:971-980.
21. Pederson CTH. Preparation of some 4-substituted seleno-semicarbazides. Acta Chemica Scandinavica 1963;17:1459-1461.
22. Okhawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissue by thioberbituric acid reaction. Annal Biochem 1979;95:351-358.
23. Sedlack J, Lindsay RN. Estimation of total protein bound and non-protein sulphydryl groups in tissue with ellman reagent. Annal Biochem 1968;25:192-205.
24. Habig WH, Pabst MJ, Jacoby WB. Glutathione-S-transferase, the first enzymatic step in marcapturic acid formation. J Biol Chem 1974;249:7130-7139.
25. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxi-dase. J Lab Clin Med 1967;70:158-169.
26. Luck HA. Spectrophotometric method for estimation of cat-alase In: Bergmeyer HV, Editor. Methods of enzymatic analysis. New York: Academic Press; 1963. p. 886-888.
27. Marklund S, Marklund G. Involvement of the superoxide anion radical in autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974;47: 469-474.
28. McCord JM, Fridovich I. Superoxide dismutase: an enzymatic function for erythrocuprein (hemoprotein). J Biol Chem 1969;244:6049-6055.
29. Green LC, Luzuriaga RKD, Wagner DA, Rand W, Istfan N, Young VR, Tannenbaum SR. Nitrate biosynthesis in man. Proc Natl Acad Sci USA 1981;78:7764-7768.
30. Carl Allinson MJ. A specic enzymatic method for the determination of creatine and creatinine in blood. J Biol Chem 1944;16:169-174.
31. Mather A, Roland D. The automated thiosemicarbazide-diacetyl monoxime method for plasma urea. Clin Chem 1969; 15:394-396.
32. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the folinphenol reagent. J Biol Chem 1951; 193:265-276.
33. Singh J, Hamid R, Reddy BS. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the post initiation stage of colon carcino-genesis. Cancer Res 1997;57:3465-3470.
34. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
35. Baliga R, Ueda N, Walker PD, Shah SV. Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev 1999;31:971-997.
36. Baek SM, Kwon CH, Kim JH, Woo JS, Jung JS, Kim YK. Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells. J Lab Clin Med 2003;142:178-186.
37. Husain K, Morris C, Whitworth C, Trammell GL, Rybak LP, Somani SM. Protection by ebselen against cisplatin-induced nephrotoxicity: antioxidant system. Mol Cell Biochem 1998; 178:127-133.
38. Rana SV, Allen T, Singh R. Inevitable glutathione, then and now. Ind J Exp Biol 2002;40:706-716.
39. Mistry P, Merazga Y, Spargo DJ, Riley PA, McBrien DC. The effects of cisplatin on the concentration of protein thiols and glutathione in the rat kidney. Cancer Chemother Pharmacol 1991;28:277-282.
40. Hayes JD, Pulford DJ. The glutathione- S -transferase super-gene family: regulation of GST and the contribution of isoen-zyme to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995;30:445-600.
41. Baliga R, Zhang Z, Baliga M, Ueda N, Shah SV. In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int 1998;53:394-401.
42. Michel T, Feron O. Nitric oxide synthase: which, where, how, and why? J Clin Invest 1997;100:2146-2152.
43. Srivastava RC, Farookh A, Ahmad N, Misra M, Hasan SK, Husain MM. Evidence for the involvement of nitric oxide in cisplatin-induced toxicity in rats. Biometals 1996;9: 139-142.
44. Kuhad A, Tirkey N, Pilkhwal S, Chopra K. 6-Gingerol prevents cisplatin-induced acute renal failure in rats. Biofactors 2006;26:189-200.
45. Chirino YI, Hernandez-Pando R, Pedraza-Chaveri J. Perox-ynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats. BMC Pharmacol 2004;30:4-20.
46. Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoper-oxide H synthase (cyclooxygenases)-1 and 2. J Biol Chem 1996;271:33157-33160.
47. Ledinghen V, Liu H, Zhang F, Lo CR, Subbarmaiah K, Dan-nenberg AJ, Czaja MJ. Induction of cyclooxygenase-2 by tumour promoters in transformed P4502E1-expressing hepa-tocytes. Carcinogenesis 2002;23:73-79.
48. Masfferer JL, Seibert K, Zwefel B, Needleman P. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc Natl Acad Sci USA 1992;89:3917-3921.
49. Sirois J, Richards JS. Purifi cation and characterization of a novel, distinct isoform of prostaglandin endoperoxide synthase induced by human chorionic gonadotropin ingranulosa cells of rat preovulatory follicles. J Biol Chem 1992;267: 6382-6388.
50. Singh J, Hamid R, Reddy BS. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the post initiation stage of colon carcino-genesis. Cancer Res 1997;57:3465-3470.
51. Tao L, Kramer PM, Wang W, Yang S, Lubet RA, Steele VE, Pereira MA. Altered expression of c-myc, p16 and p27 in rat colon tumors and its reversal by short term treat ment with chemopreventive agents. Carcinogenesis 2002;23: 1447-1454.
52. Lieberthal W, Triaca V, Levine J. Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis. Am J Physiol 1996;270:700-708.
53. Taguchi T, Nazneen A, Abid MR, Razzaque MS. Cisplatin associated nephrotoxicity and pathological events. Contrib Nephrol 2005;148:107-121.
54. Naziroglu M, Karaoglu A, Aksoy AO. Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology 2004; 195:221-230.